AMP, along with the daily practice of SKY, during normal life (pre-COVID-19 phase) reduced mRNA expression of IL1β, IL6, and TNF and increased mRNA expression of SOD, catalase, and GPx. The gene discussed is SOD1; the disease is COVID-19.